- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CMPS
Recent news which mentions CMPS
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
From Benzinga
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
From Benzinga
This Psychedelics Unicorn's Stock Is Up 50% In One Month—Beating Bitcoin, Ethereum And Dogecoin
November 04, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
October 29, 2021
From Benzinga
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent
October 26, 2021
From Benzinga
These 4 Psychedelic Biotech Stocks Are Leading the Pack
October 26, 2021
From Motley Fool
Phase 2 Trial On Ayahuasca's Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race
October 20, 2021
From Benzinga
Psychedelic Unicorn Compass Pathways Receives New Patent Approval
October 20, 2021
Tickers
CMPS
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
From Benzinga
This Company Just Extended its Reach into the United Kingdom by Opening its First Ketamine Therapy Clinic
October 18, 2021
From Benzinga
From Benzinga
From MarketWatch
3 Biotech Stocks With Huge Catalysts This Fall
September 29, 2021
From Motley Fool
Is Ketamine A Psychedelic? Depends On Who You Ask
September 22, 2021
From Benzinga
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
September 20, 2021
From Benzinga
Compass: Psychedelics Unicorn Expands Portfolio Beyond Psilocybin Into Psychedelics 2.0
September 15, 2021
From Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 08, 2021
From Benzinga
3 Biotech Stocks Wall Street Expects to Double Soon
September 07, 2021
From Motley Fool
From Benzinga
Open-Minded? Buy This Game-Changing Psychedelics Stock Now
August 26, 2021
Tickers
CMPS
From Motley Fool
From Motley Fool
Atai Life Sciences To Research Potent Psychedelic Herb Salvia Divinorum Through Its New Subsidiary
August 12, 2021
From Benzinga
COMPASS Pathways plc (CMPS) Q2 2021 Earnings Call Transcript
August 11, 2021
Tickers
CMPS
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.